Latest Strategic Partnership News

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.

RMA Global Limited reported a robust Q3 FY25, achieving a 21% revenue increase to $5.5 million and marking its third consecutive quarter of positive operating cash flow, driven by US market expansion and the strategic acquisition of Curated Social.

BrainChip Holdings advanced its neuromorphic AI technology through significant contracts with the Swedish National Space Agency and the U.S. Air Force, while exploring a potential redomiciling to the US. The company reported steady cash outflows and ongoing strategic partnerships.

Decidr AI Industries signals a strategic pivot to AI with a successful $11 million capital raise, new multi-year contracts, and expanded global partnerships, driving early commercial traction and robust e-commerce growth.

Murray Cod Australia Ltd reports a remarkable 192% biomass increase, setting the stage for expanded domestic and international sales from May 2025. The company also advances sustainability certifications and strengthens its board to support growth.

Tivan Limited reported significant progress in Q1 2025, including advancing a binding joint venture with Sumitomo Corporation for its Speewah Fluorite Project and securing seven exploration licenses for its Turiscai copper-gold project in Timor-Leste.

Micro-X Ltd has secured a $5.6 million strategic partnership with Malaysian firm Billion Prima and raised $4 million in capital, marking a pivotal shift towards medical imaging while progressing key security and health technology projects.

NH3 Clean Energy has reported a significant uplift in the value of its WAH2 clean ammonia project following completion of Pre-FEED engineering, alongside strategic export agreements and a recent capital raise.

Brazilian Rare Earths Limited (ASX:BRE) reported exceptional exploration results in the March 2025 quarter, including record high-grade rare earth assays at Monte Alto and Pelé projects, alongside a strategic royalty agreement with Rio Tinto for its Amargosa Bauxite-Gallium Project.

Osteopore Limited reported a robust 26% quarter-on-quarter revenue increase in Q1 CY25, bolstered by a key Singapore subsidy listing and a strategic pivot away from its dental project to sharpen commercial focus.

Talius Group reported a solid March quarter with rising revenue, a strategic partnership with Lifestyle SA, and the rollout of its proprietary RTLS software, signaling strong momentum in aged care technology.

Cavalier Resources has extended its non-binding $11 million US stream finance term sheet with Raptor International, aiming to fully fund the development of the Crawford Gold Project Stage 1 open pit and near-mine drilling. A revised Pre-Feasibility Study underscores strong project economics with a 580% IRR and a 9-month payback period.